Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Pei Shang, Mingqin Zhu, Matthew Baker, Jiachun Feng, Chunkui Zhou & Hong-Liang Zhang. (2020) Mechanical ventilation in Guillain–Barré syndrome. Expert Review of Clinical Immunology 16:11, pages 1053-1064.
Read now
Read now
Joanna Moncrieff. (2009) A Critique of the Dopamine Hypothesis of Schizophrenia and Psychosis. Harvard Review of Psychiatry 17:3, pages 214-225.
Read now
Read now
Henry. C. Tuckwell. (2001) On distributions of physiological and anatomical variables in pathological conditions: dopamine d2 receptors in schizophrenia and their occupancies after drug treatment. Journal of Theoretical Medicine 3:3, pages 213-220.
Read now
Read now
David Copolov & Jeremy Crook. (2000) Biological markers and schizophrenia. Australian and New Zealand Journal of Psychiatry 34:sup2, pages S108-S112.
Read now
Read now
Articles from other publishers (12)
Troels Boldt Rømer, Rose Jeppesen, Rune Haubo Bojesen Christensen & Michael Eriksen Benros. (2023) Biomarkers in the cerebrospinal fluid of patients with psychotic disorders compared to healthy controls: a systematic review and meta-analysis. Molecular Psychiatry 28:6, pages 2277-2290.
Crossref
Crossref
Johan Spoov. (2022) The Mini-TRH Test. Pharmacopsychiatry 56:02, pages 51-56.
Crossref
Crossref
Boris B. Quednow, Mark A. Geyer & Adam L. Halberstadt. 2020. Handbook of the Behavioral Neurobiology of Serotonin. Handbook of the Behavioral Neurobiology of Serotonin
711
743
.
Nora W.A. van de Kerkhof, Durk Fekkes, Frank M.M.A. van der Heijden, Jos I.M. Egger & Willem M.A. Verhoeven. (2015) Relationship between Plasma Homovanillic Acid and Outcome in Patients with Psychosis Spectrum Disorders. Neuropsychobiology 71:4, pages 212-217.
Crossref
Crossref
Boris B. Quednow, Mark A. Geyer & Adam L. Halberstadt. 2010. Handbook of the Behavioral Neurobiology of Serotonin. Handbook of the Behavioral Neurobiology of Serotonin
585
620
.
Yoshitaka Kumakura, Paul Cumming, Ingo Vernaleken, Hans-Georg Buchholz, Thomas Siessmeier, Andreas Heinz, Thorsten Kienast, Peter Bartenstein & Gerhard Gründer. (2007)
Elevated [
18
F]Fluorodopamine Turnover in Brain of Patients with Schizophrenia: An [
18
F]Fluorodopa/Positron Emission Tomography Study
. The Journal of Neuroscience 27:30, pages 8080-8087.
Crossref
Crossref
Mary Ann Richardson, Laura L. Read, Margaret A. Reilly, James D. Clelland & Catherine L. Taylor Clelland. (2006) Analysis of Plasma Biopterin Levels in Psychiatric Disorders Suggests a Common BH4 Deficit in Schizophrenia and Schizoaffective Disorder. Neurochemical Research 32:1, pages 107-113.
Crossref
Crossref
David Copolov & Jeremy Crook. (2000) Biological markers and schizophrenia. Australian and New Zealand Journal of Psychiatry 34:(Suppl.), pages S108-S112.
Crossref
Crossref
Leif H Lindström, Ola Gefvert, Gisela Hagberg, Tommie Lundberg, Mats Bergström, Per Hartvig & Bengt Långström. (1999) Increased dopamine synthesis rate in medial prefrontal cortex and striatum in schizophrenia indicated by L-(β-11C) DOPA and PET. Biological Psychiatry 46:5, pages 681-688.
Crossref
Crossref
Ing-Marie Wieselgren & Leif H Lindström. (1998) CSF levels of HVA and 5-HIAA in drug-free schizophrenic patients and healthy controls: a prospective study focused on their predictive value for outcome in schizophrenia. Psychiatry Research 81:2, pages 101-110.
Crossref
Crossref
Stephen H. Curry. (1997) Commentary. Journal of Clinical Psychopharmacology 17:2, pages 124-126.
Crossref
Crossref
Henry C Tuckwell & James A Koziol. (1996) On the concentration of 5-hydroxyindoleacetic acid in schizophrenia: A meta-analysis. Psychiatry Research 59:3, pages 239-244.
Crossref
Crossref